- Open Access
Circ_0029803 serves as the sponge of miR-216b-5p to promote the progression of colorectal cancer by regulating SKIL expression
World Journal of Surgical Oncology volume 19, Article number: 268 (2021)
Circular RNA 0029803 (circ_0029803) was found to be upregulated in colorectal cancer (CRC) tissues, but its function and underlying molecular mechanism are not studied in CRC.
The expression levels of circ_0029803, microRNA-216b-5p (miR-216b-5p), and ski-oncogene-like (SKIL) were measured by quantitative real-time polymerase chain reaction (qRT-PCR). RNase R treatment was used to affirm the existence of circ_0029803. Cell proliferation, apoptosis, migration, and invasion were assessed by colony formation, flow cytometry, and Transwell assays, respectively. A glucose and lactate assay kit was used to detect glucose consumption and lactate production. Western blot was applied to analyze the levels of all proteins. Dual-luciferase reporter assay was performed to assess the relationship between miR-216b-5p and circ_0029803 or SKIL. Tumor xenograft models were established to elucidate the effect of circ_0029803 in vivo.
Circ_0029803 expression was enhanced in CRC tissues and cells, and the 5-year overall survival rate of patients with high circ_0029803 expression was substantially reduced. Circ_0029803 depletion retarded proliferation, migration, invasion, EMT and glycolysis of CRC cells in vitro as well as the tumor growth in vivo. Mechanically, circ_0029803 could serve as miR-216b-5p sponge to regulate its expression, and miR-216b-5p knockdown reversed the inhibition of si-circ_0029803 on the malignant behaviors of CRC cells. Additionally, as the target mRNA of miR-216b-5p, SKIL could counteract the inhibitory effect of miR-216b-5p on the development of CRC cells. Importantly, silencing circ_0029803 reduced SKIL expression via sponging miR-216b-5p.
Circ_0029803 knockdown hindered proliferation, migration, invasion, EMT, and glycolysis and promoted apoptosis in CRC cells by modulating the miR-216b-5p/SKIL axis.
Colorectal cancer (CRC) is a type of malignant tumor, and its incidence is on the rise in both men and women because of irregular lifestyle and dietary habits . Despite significant advances in clinical treatment, patients with CRC have a poor prognosis due to advanced diagnosis and rapid metastasis of the tumors . Therefore, it is urgently necessary to understand the molecular mechanisms that induce CRC growth and metastasis.
Circular RNA (circRNA) is a special type of non-coding RNA (ncRNA), which is stable and abundant due to its covalently closed structure , and it has been widely introduced to be involved in the occurrence and development of cancers [4, 5]. Lately, circRNAs were found to be differentially expressed in CRC tissues compared to adjacent normal tissues and associated with the biological behaviors of cancer cells [6,7,8]. Zhang et al. suggested that circRNA dedicator of cytokinesis 1 (circ_DOCK1) acted miR-132-3p sponge to regulate the expression of ubiquitin-specific protease 11 (USP11), thereby regulating cell growth, metastasis, and apoptosis in CRC . Besides, hsa_circ_0000231 promoted cell glycolysis and progression in CRC by regulating miR-502-5p/Myosin VI (MYO6) axis . Circ_0082182 was reported to exert its tumor promoter function in CRC cells by sponging miR-411 or miR-1205 to activate the Wnt/β-catenin pathway . Furthermore, circ_0001136/miR-1205/glutamate ionotropic receptor kainate type subunit 3 (GRIK3) regulated the malignant progression of CRC in vitro and in vivo . In addition, overexpression of circLgr4 facilitated self-renewal of CRC stem cells, tumorigenesis, and invasion . Although circRNAs related to CRC progression have been widely reported, there are still numerous circRNAs whose functions have not been explored. For example, Li et al. found that circ_0029803 was upregulated in CRC tissues through RNA-Seq . However, its functions and potential mechanisms have never been studied.
CircRNA contains microRNA (miRNA) response elements (MREs), which can act as a competitive endogenous RNA (ceRNA) of miRNA to regulate the expression of target mRNAs . Dysregulation of miRNA expression has also been found to be closely related to the development of CRC. For instance, miR-708  and miR-193a-3p  could act as tumor suppressors to inhibit the progression of CRC, while miR-501-3p  and miR-17  could promote the development of CRC. MiR-216b-5p was reported to act as a tumor-suppressive RNA to suppress tumorigenesis in pancreatic cancer  and breast cancer . Furthermore, Sun et al. revealed that miR-216b-5p might be related to CRC cell activity and glycolysis, but the specific mechanisms of miR-216b-5p in CRC remains unclear. Ski-oncogene-like (SKIL or SnoN), an inverse regulator of TGF-β signaling, has been shown to function as an oncogene in oral cancer . However, it served as a cancer suppressor in the early stages of some human cancers , which aroused our concern to investigate the role of SKIL in CRC.
In the current study, the expression of circ_0029803 in CRC tissues and cells was detected, and we explored its biological functions in vitro and in vivo. Moreover, a novel molecular mechanism mediated by circ_0029803 in CRC was investigated to further understand the pathogenesis of CRC.
Materials and methods
Tissue samples and cell culture
Tumor tissues and paracancerous tissues from 62 patients with CRC were collected at Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology. The collection of tissue samples was permitted by the Human Ethics Committee of Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology, and these CRC patients provided the written informed consents. The collected CRC tissues were divided into two groups based on the expression of circ_0029803: one group with high circ_0029803 expression (n=35) and another group with low circ_0029803 expression (n=27).
CRC cell lines, HCT-116 and SW480, were bought from Procell (Wuhan, China), and human colon epithelial cell line, NCM460, was obtained from SUER (Shanghai, China). All cell lines were hatched in Roswell Park Memorial Institute 1640 (RPMI 1640, Hyclone, South Logan, UT, USA) medium containing 10% fetal bovine serum (FBS, Hyclone) at 37°C in an incubator containing 5% CO2.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Trizol reagent (Invitrogen, Carlsbad, CA, USA) was applied for total RNA extraction from CRC cell lines and tissues. After quality detection, the complementary DNA (cDNA) was synthesized using PrimeScript RT kit (Takara, Dalian, China). Subsequently, qRT-PCR was carried out using PrimeScript RT Master Mix (Takara). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6 was used as internal reference of circ_0029803 and SKIL or miR-216b-5p, and the relative expression level was analyzed by the 2−∆∆Ct method. The primer sequences used in this paper were as follows: circ_0029803, Forward (F): 5′-AGTTACCTCGGGGAATGGTGA-3′, Reverse (R): 5′-AATGCTATTTCTCTACATGCCGAC-3′. GAPDH, F: 5′-GGAGTCCACTGGCGTCTTCA-3′, R: 5′-GGTTCACACCCATGACGAAC-3′. miR-216b-5p, F: 5′-GGGGAAATCTCTGCAGGCAA-3′, R: 5′-CAGTGCAGGGTCCGAGGT-3′. U6, F: 5′-CTCGCTTCGGCAGCACA-3′, R: 5′-AACGCTTCACGAATTTGCGT-3′. SKIL, F: 5′-AGAGGCTGAATATGCAGGACA-3′, R: 5′-CCAAAGCAAGCAACAAACAA-3′. These primer sequences were synthesized by GenePharma (Shanghai, China).
Nuclear-cytoplasmic fractionation and RNase R treatment
The RNA of cytoplasm and nuclear was separated by PARIS kit (Invitrogen). Briefly, HCT-116 and SW480 cells were collected and centrifuged, the supernatant was used to extract the RNA of cytoplasm, and the precipitation was applied to acquire nuclear RNA. Besides, GAPDH and U6 were used as the controls of cytoplasm and nuclear, respectively.
RNA was isolated from HCT-116 and SW480 cells, and it was treated with or without RNase R (Epicentre Technologies, Madison, WI, USA) at 37°C for 30 min. qRT-PCR was then used to examine the stability of circ_0029803.
For circ_0029803 interference, small interfering RNA targeting circ_0029803 (si-circ_0029803) and the control si-NC were synthesized by GenePharma. Moreover, miR-216b-5p mimics (miR-216b-5p), miR-216b-5p inhibitor (anti-miR-216b-5p), and their matched controls (miR-NC and anti-miR-NC) were designed by GenePharma. The overexpression plasmid of SKIL and its negative control (vector), lentivirus-sh-circ_0029803 and control sh-NC were provided by Fenghui Biotechnology Company (Changsha, China). Cell transfection was conducted using Lipofectamine 3000 (Invitrogen).
Colony formation assay
The transfected HCT-116 and SW480 cells were evenly spread in 6-well plates (200 cells/well) and placed in a 37°C incubator. 2 weeks later, the cells were fixed with methanol and stained with 0.5% crystal violet (Beyotime, Beijing, China) for 20 min, and the number of colonies was then counted using a light microscope.
Cell apoptosis assay
The apoptosis of HCT-116 and SW480 cells was detected using the Annexin V fluorescein isothiocynate (FITC)/propidium iodide (PI) apoptosis detection kit (Beyotime). The 6-well plates with transfected CRC cells were placed in a 37°C incubator for 48 h. Next, cells were harvested, FITC and PI were applied to stain the cells for 20 min in the absence of light, and the cells were analyzed by flow cytometry (FlowCam, Shanghai, China).
Analysis of cell migration and invasion
Transwell assay was used to analyze the migration and invasion ability of cells. The difference between them was that the Transwell chamber was coated with Matrigel (Solarbio, Beijing, China) during the invasion experiment. The transfected CRC cells in 200 μL of serum-free medium were seeded into the upper chamber, and 500 μL of complete medium was added into the bottom chamber. Cells were then incubated at 37°C for 24 h. Cells migrated or invaded through the chamber were stained with 0.1% crystal violet (Beyotime) for 20 min and counted under an inverted microscope.
Western blot assay
CRC tissues and transfected CRC cells were lysed using RIPA (Beyotime). The extracted protein was isolated and transferred to the polyvinylidene difluoride (PVDF) membranes (Beyotime). After blocking with skim milk powder for 2 h, the membranes were incubated overnight with primary antibodies at 4°C. After washing with TBST, horseradish peroxidase (HRP)-labeled secondary antibody (1:5000, Abcam, Cambridge, MA, USA) was applied to incubate the membranes. Finally, the bands were visualized using an ECL detection kit (Beyotime). The primary antibodies were used as follows: E-cadherin (1:200, Abcam), N-cadherin (1:500, Abcam), Vimentin (1:200, Abcam), Hexokinase2 (HK2, 1:1000, Abcam), SKIL (0.5 μg/ML, Abcam), and β-actin (1:3000, Abcam).
Glucose consumption and lactate production measurement
The transfected HCT-116 and SW480 cells were tiled into 6-well plates and incubated for 48 h. Subsequently, the concentrations of glucose and lactate in the supernatant of medium were examined by a glucose and lactate assay kit (Sigma-Aldrich, St. Louis, MO, USA). Glucose consumption was calculated by subtracting the concentration of glucose in the medium at a specific time point from the concentration of glucose in the fresh complete medium. Lactate production was obtained by subtracting the concentration of lactate in the fresh original medium from the concentration of lactate in the collected supernatant.
Dual-luciferase reporter assay
For circ_0029803, the sequences of wild-type (WT) or mutant (MUT) containing miR-216b-5p binding sites or not were inserted into the pmirGLO vector (Promega, Madison, WI, USA). For SKIL, the 3′ untranslated region (3′UTR) of WT or MUT containing miR-216b-5p binding sites or not were inserted into the pmirGLO vector. Then, these report plasmids were respectively co-transfected with miR-216b-5p or miR-NC into CRC cell lines. At 36 h after the transfection, the luciferase activity was checked by a dual-luciferase reporter kit (Promega).
The 4-week-old BALB/c nude mice were used to construct a tumor xenograft model. SW480 cells were first stably transfected with sh-circ_0029803 or control sh-NC, and then, the transfected SW480 cells were inoculated into the nude mice, classified into sh-circ_0029803 group and sh-NC group. Tumor volume was measured and calculated every week. Five weeks later, all mice were euthanized and the tumor tissues were weighed and collected for the detection of circ_0029803, miR-216b-5p and SKIL expression levels. The experiment was permitted by the Animal Research Committee of the Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology.
IHC staining analysis
Five-micrometer-thickness tissue sections were prepared, followed by dewaxing and blocking. Then, tissue sections were probed with the primary antibody targeting SKIL at 4°C overnight and proved with the secondary antibody for 1 h. Subsequently, tissue sections were stained using a 3, 3′-diaminobenzidine (DAB) kit (Abcam).
All data were processed by using GraphPad Prism 7 software (GraphPad Inc., La Jolla, CA, USA). All data were repeated at least three times and appeared as the mean ± standard deviation (SD).The difference between two groups was analyzed by Student’s t-test, and multiple group comparisons were assessed using one-way analysis of variance (ANOVA) analysis. P < 0.05 was regarded as a statistically distinct difference.
Increased circ_0029803 expression was associated with the progression of CRC
To explore the role of circ_0029803 in CRC, its expression in CRC tissues and cell lines was measured by qRT-PCR. The results showed that circ_0029803 expression was aggrandized in CRC tissues (n = 62) compared with adjacent normal tissues (Fig. 1A). As displayed in Table 1, we analyzed the correlation between circ_0029803 expression and clinicopathological features of the 62 patients. The data showed that high expression of circ_0029803 was related to larger tumor sizes (P=0.011). Consistently, the expression of circ_0029803 was increased in CRC cell lines (HCT-116 and SW480) compared to normal colon epithelial cell line NCM460 (Fig. 1B). The cell nuclear-cytoplasmic fraction assay showed that circ_0029803 was primarily located in the cytoplasm of HCT-116 and SW480 cells (Fig. 1C, D). RNase R, an exoribonuclease, has been widely introduced to degrade linear RNA from its 3′ to 5′ end, but does not act on circRNA . As shown in Fig. 1E, F, circ_0029803 was resistant to RNase R digestion, while RNase R could degrade linear mRNA. Besides, The Kaplan-Meier overall survival (OS) curve showed that the 5-year survival rate of patients with high circ_0029803 expression was lower than that of patients with low circ_0029803 expression (Fig. 1G). The data suggested that circ_0029803 might be a key factor in the regulation of CRC progression.
Circ_0029803 knockdown suppressed the progression of CRC cells in vitro
Due to the high expression of circ_0029803 in CRC, we knocked down circ_0029803 in CRC cells to explore its function. As displayed in Fig. 2A, B, circ_0029803 expression was evidently decreased after the transfection of si-circ_0029803 into HCT-116 and SW480 cells. Then, colony formation assay demonstrated that the cloning ability of HCT-116 and SW480 cells was inhibited after the downregulation of circ_0029803 (Fig. 2C). The results of flow cytometry assay showed that circ_0029803 knockdown augmented the apoptosis rate of the cells (Fig. 2D, E). Transwell assay further indicated that when circ_0029803 expression was silenced in HCT-116 and SW480 cells, cell migration and invasion abilities were reduced (Fig. 2F, G). It is well known that EMT plays a crucial role in the process of tumor metastasis . Therefore, we also studied the effect of si-circ_0029803 on the expression of EMT marker proteins, including E-cadherin, N-cadherin, and Vimentin, by western blot in HCT-116 and SW480 cells. As shown in Fig. 2H, I, interference with circ_0029803 strikingly increased the protein expression of E-cadherin and decreased the protein levels of N-cadherin and Vimentin, suggesting that circ_0029803 knockdown restrained EMT of CRC cells. In addition, the knockdown of circ_0029803 significantly reduced glucose consumption (Fig. 2J, K), lactate production (Fig. 2L, M), and the protein level of HK2 (Fig. 2N, O) in HCT-116 and SW480 cells. These results indicated that downregulation of circ_0029803 repressed colony formation, migration, invasion, EMT, and glycolysis of CRC cells, and induced cell apoptosis in vitro.
Circ_0029803 served as a sponge for miR-216b-5p
CircRNAs have been reported to exert their biological functions as miRNA sponges to regulate miRNA expression . To investigate whether circ_0029803 could act as a sponge for miRNAs in CRC cells, we predicted the possible binding miRNAs of circ_0029803 by StarBase v2.0, and miR-216b-5p was found to have complementary sites that bind to circ_0029803 (Fig. 3A). To validate the direct binding between them, dual-luciferase reporter assay was performed in HCT-116 and SW480 cells. The results revealed that miR-216b-5p distinctly decreased the luciferase activity in cells transfected with circ_0029803 WT compared to control, whereas did not show significant effect on that of circ_0029803 MUT (Fig. 3B, C). Next, we examined the expression of miR-216b-5p in CRC tissues and cells by qRT-PCR. The data showed that miR-216b-5p expression was downregulated in CRC tissues and cells compared with normal tissues and cells (Fig. 3D, E). Moreover, circ_0029803 knockdown increased miR-216b-5p expression in HCT-116 and SW480 cells (Fig. 3F, G). The above results implied that circ_0029803 directly targeted miR-216b-5p and regulated its expression in CRC cells.
Circ_0029803 knockdown suppressed the progression of CRC cells by targeting miR-216b-5p
We have proved that miR-216b-5p was a target miRNA of circ_0029803. Next, we investigated whether miR-216b-5p could affect the function of circ_0029803 in CRC cells by the recovery experiments. First, qRT-PCR results showed that anti-miR-216b-5p could reverse the upregulation effect of si-circ_0029803 on miR-216b-5p expression in HCT-116 and SW480 cells (Fig. 4A, B). Colony formation, flow cytometry, and Transwell assays were respectively demonstrated that interference with miR-216b-5p in HCT-116 and SW480 cells alleviated the inhibition of circ_0029803 knockdown on cell clone formation (Fig. 4C, D), migration, and invasion (Fig. 4G, H), and partially eliminated the promotion effect of circ_0029803 knockdown on cell apoptosis (Fig. 4E, F). Furthermore, the effect of si-circ_0029803 on levels of EMT marker proteins described in Fig. 2H, I could also be overturned by anti-miR-216b-5p (Fig. 4I, J). Simultaneously, the inhibitory effect of si-circ_0029803 on glucose consumption (Fig. 4K, L), lactate production (Fig. 4M, N), and the protein level of HK2 (Fig. 4O, P) in HCT-116 and SW480 cells was counteracted by silencing miR-216b-5p. The results supported that circ_0029803 modulated the progression of CRC cells by acting as a sponge of miR-216b-5p.
Circ_0029803 positively modulated SKIL expression via sponging miR-216b-5p
Subsequently, we searched the downstream target mRNAs of miR-216b-5p by StarBase v2.0 and found that miR-216b-5p could bind to the 3′ UTR region of SKIL (Fig. 5A). Next, dual-luciferase reporter assay showed that the transfection of miR-216b-5p in HCT-116 and SW480 cells could markedly dwindle the luciferase activity with SKIL 3′ UTR WT transfection compared to miR-NC, while the luciferase activity of SKIL 3′ UTR MUT was not significantly affected by over-expression of miR-216b-5p (Fig. 5B, C). To understand the role of SKIL in CRC, we measured SKIL expression in CRC at mRNA and protein levels by qRT-PCR and western blot. The data showed that the mRNA and protein levels of SKIL were upregulated in CRC tissues and cells (Fig. 5D–G). Additionally, overexpression of miR-216b-5p in HCT-116 and SW480 cells inhibited SKIL expression, including mRNA and protein levels (Fig. 5H–K). Given that circ_0029803 could direct target miR-216b-5p, we speculated whether circ_0029803 could regulate the expression of SKIL by targeting miR-216b-5p. The results indicated that when circ_0029803 was silenced in HCT-116 and SW480 cells, the mRNA and protein levels of SKIL were declined, and the effect of si-circ_0029803 on SKIL expression was reversed by anti-miR-216b-5p (Fig. 5L–O).
SKIL could reverse the biological functions mediated by miR-216b-5p in CRC cells
To determine whether miR-216b-5p regulated the biological behavior of CRC cells by SKIL, rescue experiments were conducted. HCT-116 and SW480 cells were transfected with the following four groups: miR-NC, miR-216b-5p, miR-216b-5p + vector, and miR-216b-5p + SKIL, and the transfection efficiency was verified by qRT-PCR and western blot (Fig. 6A–D). The results showed that miR-216b-5p overexpression retarded clone formation (Fig. 6E, F), migration, and invasion (Fig. 6I, J), and promoted apoptosis (Fig. 6G, H) of HCT-116 and SW480 cells; however, these effects could be weakened by overexpressing SKIL. Also, upregulation of miR-216b-5p hampered EMT in HCT-116 and SW480 cells, which was reflected in the increase of E-cadherin protein expression and the decrease of N-cadherin and Vimentin protein levels, while the inhibition of miR-216b-5p on EMT was eliminated by overexpression of SKIL (Fig. 6K, L). As with si-circ_0029803, overexpression of miR-216b-5p impeded glucose consumption (Fig. 6M, N), lactate production (Fig. 6O, P), and HK2 protein expression (Fig. 6Q, R) in HCT-116 and SW480 cells, and SKIL could also invert these effects.
Circ_0029803 knockdown inhibited the growth of CRC tumors by regulating miR-216b-5p/SKIL axis in vivo
To further explore the effect of circ_0029803 on CRC cells in vivo, SW480 cells stably transfected with sh-circ_0029803 or sh-NC were injected subcutaneously into nude mice, and the tumor volumes were measured weekly after injection. As demonstrated in Fig. 7A, B, the volume and weight of tumors in the sh-circ_0029803 group were significantly smaller than those in the negative control. Meanwhile, examined by qRT-PCR, circ_0029803 (Fig. 7C) expression was notably decreased in sh-circ_0029803 group compared with that in the sh-NC group. In contrast, miR-216b-5p showed high expression in the sh-circ_0029803 group (Fig. 7D). SKIL mRNA (Fig. 7E) and SKIL protein (Fig. 7F) were poorly expressed in sh-circ_0029803 group compared with those in the sh-NC group by qRT-PCR and western blot assays. Consistently, the expression of SKIL was also declined in the sh-circ_0029803 group by IHC staining analysis (Fig. 7G). The above data indicated that silencing circ_0029803 hampered tumor growth in vivo by modulating miR-216b-5p/SKIL axis.
As a new ncRNA, circRNA is implicated in various physiological and pathological processes of human cancers . Some circRNAs with abnormal expression have also been found in CRC, such as circ_0026344 , circ_0021977 , and circ_0004585 . These circRNAs could regulate the growth and metastasis of tumor cells as well as the occurrence of tumors by acting as a sponge for miRNA. Previously, circ_0029803 was found to be overexpressed in CRC tissues through RNA-Seq, but the result has not been verified. In our study, circ_0029803 was confirmed to be increased in CRC tissues and cells by qRT-PCR, and we notarized its existence through RNase R treatment. Additionally, CRC patients exhibiting high circ_0029803 expression had shorter overall survival than those patients exhibiting low circ_0029803 expression, suggesting that circ_0029803 might be a pivotal regulator of CRC.
Subsequently, cell function tests showed that interfering with circ_0029803 retarded proliferation, migration, and invasion of CRC cells, but promoted apoptosis. EMT is characterized by the loss of epithelial features and the acquisition of mesenchymal phenotypes, leading to cancer metastasis and development . E-cadherin, N-cadherin, and Vimentin were considered to be EMT markers . Glycolysis reflects the extent to which cells metabolize, and is characterized by glucose consumption and lactate production. Moreover, HK2 is a key enzyme in glycolysis . When circ_0029803 was knocked down, the levels of N-cadherin and Vimentin were decreased, and E-cadherin expression level was elevated. Besides, glucose consumption, lactate production, and HK2 protein level were reduced in CRC cells, suggesting that EMT and glycolysis were inhibited. Based on these results, we believed that circ_0029803 might be an oncogenic driver in CRC.
CircRNA functions as a sponge of miRNAs, thus releasing mRNA transcripts that are directly targeted by miRNAs, which is widely accepted . There were binding sites between circ_0029803 and miR-216b-5p, and we confirmed that miR-216b-5p was a target of circ_0029803. Then, we measured miR-216b-5p expression in CRC, and miR-216b-5p expression was found to be declined in CRC tissues and cells. The rescue experiments indicated that the suppressive effect caused by si-circ_0029803 on the progression of CRC cells was reversed after miR-216b-5p inhibition. These results suggested that circ_0029803 acted as a sponge of miR-216b-5p to promote the progression of CRC cells in vitro.
Subsequently, we found that SKIL was a target of miR-216b-5p. In CRC, SKIL was upregulated, and its expression was actively regulated by circ_0029803 and negatively modulated by miR-216b-5p, implying that circ_0029803 could modulate SKIL expression by serving as a ceRNA of miR-216b-5p. SKIL has been reported to play a dual role in different cancers ; it has both anticancer and carcinogenic activities depending on other genetic changes in the tumor . In our data, overexpression of miR-216b-5p suppressed proliferation, migration, invasion, EMT, and glycolysis of CRC cells and induced apoptosis, while these effects were counteracted by overexpressing SKIL, suggesting that SKIL played a role as an oncogene in CRC. In accordance with previous data, Ye et al. demonstrated that lncRNA SNHG14 facilitated the tumorigenesis and metastasis of CRC by increasing SKIL expression through sponging miR-32-5p . In vivo experiments showed that circ_0029803 knockdown impeded the growth of CRC tumors by reducing SKIL expression and enhancing miR-216b-5p expression.
Our study was the first to preliminarily exploit the role of circ_0029803 in CRC, and we provided a new mechanism to partly clarify how circ_0029083 functioned in CRC. However, there were still some limitations. For example, additional miRNAs targeted by circ_0029083 were not investigated, and the potential oncogenic pathways involved in the circ_0029083-mediated networks were lacking. Future work should focus on these points to further disclose the functional role of circ_0029083 in CRC.
Our results were the first time to demonstrate that circ_0029803 was augmented in CRC tissues and cells as an oncogene. Mechanically, circ_0029803 modulated SKIL expression through competitive binding with miR-216b-5p. Functionally, circ_0029803 promoted proliferation, migration, invasion, and EMT as well as hindered apoptosis of CRC cells by regulating miR-216b-5p/SKIL axis (Fig. 8). Therefore, circ_0029803 might be a promising molecular marker for the diagnosis of CRC.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
Quantitative real-time polymerase chain reaction
MicroRNA response elements
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. https://doi.org/10.3322/caac.21387.
Xiao Z, Qu Z, Chen Z, Fang Z, Zhou K, Huang Z, et al. LncRNA HOTAIR is a prognostic biomarker for the proliferation and chemoresistance of colorectal cancer via MiR-203a-3p-mediated Wnt/ss-catenin signaling pathway. Cell Physiol Biochem. 2018;46(3):1275–85. https://doi.org/10.1159/000489110.
Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–57. https://doi.org/10.1261/rna.035667.112.
Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, et al. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Lett. 2020;469:68–77.
Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng M, et al. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Mol Cancer. 2019;18:145.
Li C, He X, Zhang L, Li L, Zhao W. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer. BMC Cancer. 2019;19:957.
Zhong D, Li P, Gong PY. Hsa_circ_0005075 promotes the proliferation and invasion of colorectal cancer cells. Int J Biol Markers. 2019;34:284–91.
Gao C, Zhang Y, Tian Y, Han C, Wang L, Ding B, et al. Circ_0055625 knockdown inhibits tumorigenesis and improves radiosensitivity by regulating miR-338-3p/MSI1 axis in colon cancer. World J Surg Oncol. 2021;19(1):131. https://doi.org/10.1186/s12957-021-02234-1.
Zhang W, Wang Z, Cai G, Huang P. Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression. World J Surg Oncol. 2021;19(1):67. https://doi.org/10.1186/s12957-021-02173-x.
Liu Y, Li H, Ye X, Ji A, Fu X, Wu H, et al. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis. World J Surg Oncol. 2020;18(1):255. https://doi.org/10.1186/s12957-020-02033-0.
Liu R, Deng P, Zhang Y, Wang Y, Peng C. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway. World J Surg Oncol. 2021;19(1):51. https://doi.org/10.1186/s12957-021-02164-y.
Fang G, Wu Y, Zhang X. CircASXL1 knockdown represses the progression of colorectal cancer by downregulating GRIK3 expression by sponging miR-1205. World J Surg Oncol. 2021;19(1):176. https://doi.org/10.1186/s12957-021-02275-6.
Zhi X, Zhang J, Cheng Z, Bian L, Qin J. circLgr4 drives colorectal tumorigenesis and invasion through Lgr4-targeting peptide; 2019.
Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL, Yang Y. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018;37(1):325. https://doi.org/10.1186/s13046-018-1006-x.
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–8. https://doi.org/10.1038/nature11993.
Sun S, Hang T, Zhang B, Zhu L, Wu Y, Lv X, et al. miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway. Am J Transl Res. 2019;11(9):5338–56.
Lin M, Zhang Z, Gao M, Yu H, Sheng H, Huang J. MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression. Cancer Manag Res. 2019;11:5353–63. https://doi.org/10.2147/CMAR.S208233.
Wu F, Xing T, Gao X, Liu F. miR5013p promotes colorectal cancer progression via activation of Wnt/betacatenin signaling. Int J Oncol. 2019;55(3):671–83. https://doi.org/10.3892/ijo.2019.4852.
Huang C, Liu J, Xu L, Hu W, Wang J, Wang M, et al. MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1. Cancer Manag Res. 2019;11:3521–34. https://doi.org/10.2147/CMAR.S191087.
You Y, Tan J, Gong Y, Dai H, Chen H, Xu X, et al. MicroRNA-216b-5p functions as a tumor-suppressive RNA by targeting TPT1 in pancreatic cancer cells. J Cancer. 2017;8(14):2854–65. https://doi.org/10.7150/jca.18931.
Menbari MN, Rahimi K, Ahmadi A, Elyasi A, Darvishi N, Hosseini V, et al. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression. Life Sci. 2019;237:116945. https://doi.org/10.1016/j.lfs.2019.116945.
Bundela S, Sharma A, Bisen PS. Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS One. 2014;9(7):e102610. https://doi.org/10.1371/journal.pone.0102610.
Jahchan NS, Ouyang G, Luo K. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer. PLoS One. 2013;8(2):e55794. https://doi.org/10.1371/journal.pone.0055794.
Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006;34(8):e63. https://doi.org/10.1093/nar/gkl151.
Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21–45. https://doi.org/10.1016/j.cell.2016.06.028.
Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. https://doi.org/10.1016/j.molcel.2014.08.019.
Zhang M, Xin Y. Circular RNAs: a new frontier for cancer diagnosis and therapy. J Hematol Oncol. 2018;11(1):21. https://doi.org/10.1186/s13045-018-0569-5.
Shen T, Cheng X, Liu X, Xia C, Zhang H, Pan D, et al. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183. Artif Cells Nanomed Biotechnol. 2019;47:4038–45.
Lu C, Jiang W, Hui B, Rong D, Fu K, Dong C, et al. The circ_0021977/miR-10b-5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer. J Cell Physiol. 2020;235(3):2273–85.
Tian J, Xi X, Wang J, Yu J, Huang Q, Ma R, et al. CircRNA hsa_circ_0004585 as a potential biomarker for colorectal cancer. Cancer Manag Res. 2019;11:5413–23. https://doi.org/10.2147/CMAR.S199436.
Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–8. https://doi.org/10.1172/JCI39104.
Loh CY, Chai JY, Tang TF, Wong WF. The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):1118.
Garcia SN, Guedes RC, Marques MM. Unlocking the potential of HK2 in cancer metabolism and therapeutics. Curr Med Chem. 2019;26(41):7285–322.
Ma X, Liu C, Gao C, Li J, Zhuang J, Liu L, et al. circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer. J Cell Physiol. 2020;235(4):3973–83.
Zhu Q, Krakowski AR, Dunham EE, Wang L, Bandyopadhyay A, Berdeaux R, et al. Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol. 2007;27(1):324–39. https://doi.org/10.1128/MCB.01394-06.
Chia JA, Simms LA, Cozzi SJ, Young J, Jass JR, Walsh MD, et al. SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers. BMC Cancer. 2006;6(1):252. https://doi.org/10.1186/1471-2407-6-252.
Ye T, Zhang N, Wu W, Yang B, Wang J, Huang W, et al. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis; 2019.
The authors sincerely appreciate all members participated in this study.
Ethics approval and consent to participate
Written informed consent was obtained from patients with approval by Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology.
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, L., Zhu, L., Pan, S. et al. Circ_0029803 serves as the sponge of miR-216b-5p to promote the progression of colorectal cancer by regulating SKIL expression. World J Surg Onc 19, 268 (2021). https://doi.org/10.1186/s12957-021-02368-2
- Colorectal cancer